Torsades de pointes occurring in association with terfenadine use
- 5 December 1990
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA
- Vol. 264 (21), 2788-2790
- https://doi.org/10.1001/jama.264.21.2788
Abstract
Torsades de pointes is a form of polymorphic ventricular tachycardia that is associated with prolongation of the QT interval. Although found in many clinical settings, torsades de pointes is most often drug induced. This report describes the first association (exclusive of drug overdose) of symptomatic torsades de pointes occurring with the use of terfenadine in a patient who was taking the recommended prescribed dose of this drug in addition to cefaclor, ketoconazole, and medroxyprogesterone. Measured serum concentrations of terfenadine and its main metabolite showed excessive levels of parent terfenadine and proportionately reduced concentrations of metabolite, suggesting inhibition of terfenadine metabolism. We believe that a drug interaction between terfenadine and ketoconazole resulted in the elevated terfenadine levels in plasma and in the cardiotoxicity previously seen only in cases of terfenadine overdose. (JAMA. 1990;264:2788-2790)This publication has 5 references indexed in Scilit:
- INDUCTION AND INHIBITION OF RAT HEPATIC DRUG-METABOLISM BY N-SUBSTITUTED IMIDAZOLE DRUGS1987
- Effect of ketoconazole on hepatic oxidative drug metabolismClinical Pharmacology & Therapeutics, 1985
- THE EFFECT OF KETOCONAZOLE ON HEPATIC OXIDATIVE DRUG-METABOLISM IN THE RAT INVIVO AND INVITRO1985
- Inhibition of mono-oxygenase and oxidase activity of rat-hepatic cytochrome P-450 by H2-receptor blockersXenobiotica, 1984
- Inhibition of microsomal drug metabolism by histamine H2-receptor antagonists studied in vivo and in vitro in rodentsGastroenterology, 1982